An FDA-designated orphan drug that can target a key vulnerability in lung cancer shows promise in improving the efficacy of ...

How one man, along with his care team, turned an all-consuming cancer diagnosis into a management strategy with inspiration ...

Margaret and her husband, David, were able to travel to Mexico because a clinical trial drug called zoldonrasib successfully controlled her lung cancer, which had returned after treatment. Dr. Kathryn ...

Preventing this complication for those who receive a lung transplant is of the highest priority, as there ... Experimental Cancer Drug Could Streamline Standard Tuberculosis Treatment and Prevent ...

Shares of NovoCure ( NVCR 0.43%) are edging higher on Thursday. The company's stock gained 0.11% as of 3:30 p.m. ET after ...

Q1 2025 Management View Executive Chairman Bill Doyle highlighted the company’s transition to a multi-indication oncology company, emphasizing the regulatory and commercial advancements. He announced ...

Considering his family history of lung cancer, doctors recommended immediate surgery. Car said he had never thought of returning to the UK for treatment. He placed his trust in Shanghai's medical ...

Scientists at Ankara University (AU) have developed an artificial intelligence-supported application that could enable the ...

Non-small cell lung cancer: current treatment and future advances ... our 10-year forecasts for annual sales growth and operating margin remain. We sell different types of products and services ...